These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20644897)

  • 1. Intervention effects in the case of heterogeneity between three subgroups. Assessment within the framework of systematic reviews.
    Skipka G; Bender R
    Methods Inf Med; 2010; 49(6):613-7. PubMed ID: 20644897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of subgroup effects in published trials.
    Hancock MJ; Kjaer P; Korsholm L; Kent P
    Phys Ther; 2013 Jun; 93(6):852-9. PubMed ID: 23431217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice.
    Higgins J; Thompson S; Deeks J; Altman D
    J Health Serv Res Policy; 2002 Jan; 7(1):51-61. PubMed ID: 11822262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring a three-armed clinical trial with survival endpoints: Fisher's least significant difference approach.
    Chen PL; Dominik R
    J Biopharm Stat; 2004 Aug; 14(3):791-801. PubMed ID: 15468765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of subgroup-specific treatment effect in the absence of an overall effect: is there really a contradiction?
    Abrahamowicz M; Beauchamp ME; Fournier P; Dumont A
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1178-88. PubMed ID: 23939947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial sequential methods for meta-analysis.
    Kulinskaya E; Wood J
    Res Synth Methods; 2014 Sep; 5(3):212-20. PubMed ID: 26052847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.
    Lipkovich I; Dmitrienko A; Denne J; Enas G
    Stat Med; 2011 Sep; 30(21):2601-21. PubMed ID: 21786278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction effects and subgroup analyses in clinical trials: more than meets the eye?
    Sevdalis N; Jacklin R
    J Eval Clin Pract; 2008 Oct; 14(5):919-22. PubMed ID: 18373582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC
    Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.
    Willems P
    Acta Orthop Suppl; 2013 Feb; 84(349):1-35. PubMed ID: 23427903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect Modifiers and Statistical Tests for Interaction in Randomized Trials.
    Christensen R; Bours MJL; Nielsen SM
    J Clin Epidemiol; 2021 Jun; 134():174-177. PubMed ID: 34016442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flexible strategy for testing subgroups and overall population.
    Alosh M; Huque MF
    Stat Med; 2009 Jan; 28(1):3-23. PubMed ID: 18985704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes.
    Tanniou J; van der Tweel I; Teerenstra S; Roes KC
    BMC Med Res Methodol; 2016 Feb; 16():20. PubMed ID: 26891992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the decision in a validation process of a surrogate endpoint change with level of significance of treatment effect? A proposal on validation of surrogate endpoints.
    Sertdemir Y; Burgut R
    Contemp Clin Trials; 2009 Jan; 30(1):8-12. PubMed ID: 18809512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The practice of systematic reviews. V. Heterogeneity between studies and subgroup analysis].
    Scholten RJ; Assendelft WJ; Kostense PJ; Bouter LM
    Ned Tijdschr Geneeskd; 1999 Apr; 143(16):843-8. PubMed ID: 10347653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of missing participant data for dichotomous outcomes on pooled effect estimates in systematic reviews: a protocol for a methodological study.
    Akl EA; Kahale LA; Agarwal A; Al-Matari N; Ebrahim S; Alexander PE; Briel M; Brignardello-Petersen R; Busse JW; Diab B; Iorio A; Kwong J; Li L; Lopes LC; Mustafa R; Neumann I; Tikkinen KA; Vandvik PO; Zhang Y; Alonso-Coello P; Guyatt G
    Syst Rev; 2014 Nov; 3():137. PubMed ID: 25423894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.